These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2191204)

  • 1. [Biotechnological approaches to the creation of antimalarial vaccines].
    Lalaiants IE; Milovanova LS
    Med Parazitol (Mosk); 1990; (1):53-7. PubMed ID: 2191204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Achievements and problems in the development of malaria vaccines].
    Martínez-Gómez F
    Rev Latinoam Microbiol; 1993; 35(3):319-25. PubMed ID: 8047736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apical membrane antigen 1: a malaria vaccine candidate in review.
    Remarque EJ; Faber BW; Kocken CH; Thomas AW
    Trends Parasitol; 2008 Feb; 24(2):74-84. PubMed ID: 18226584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards the development of malaria vaccines.
    Malkin E; Dubovsky F; Moree M
    Trends Parasitol; 2006 Jul; 22(7):292-5. PubMed ID: 16707275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of malaria vaccines that block transmission of parasites by mosquito vectors.
    Hisaeda H; Yasutomo K
    J Med Invest; 2002 Aug; 49(3-4):118-23. PubMed ID: 12323000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characteristics of immunogenic liver-stage antigens derived from P. falciparum malarial proteins.
    Cifuentes G; Vanegas M; Martinez NL; Pirajan C; Patarroyo ME
    Biochem Biophys Res Commun; 2009 Jul; 384(4):455-60. PubMed ID: 19422790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea.
    Stirnadel HA; Beck HP; Alpers MP; Smith TA
    Genet Epidemiol; 1999; 17(1):16-34. PubMed ID: 10323182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High road, low road? Choices and challenges on the pathway to a malaria vaccine.
    Richie T
    Parasitology; 2006; 133 Suppl():S113-44. PubMed ID: 17274843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria vaccines.
    Gordon DM
    Infect Dis Clin North Am; 1990 Jun; 4(2):299-313. PubMed ID: 2189001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of candidate vaccine antigens in Plasmodium falciparum.
    Anders RF; Murray LJ; Thomas LM; Davern KM; Brown GV; Kemp DJ
    Biochem Soc Symp; 1987; 53():103-14. PubMed ID: 3332761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
    Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
    Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria vaccines: if at first you don't succeed..
    Tongren JE; Zavala F; Roos DS; Riley EM
    Trends Parasitol; 2004 Dec; 20(12):604-10. PubMed ID: 15522671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
    Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
    Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a blood-stage vaccine for malaria: are we following all the leads?
    Good MF
    Nat Rev Immunol; 2001 Nov; 1(2):117-25. PubMed ID: 11905819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune responses to the Plasmodium falciparum antigen Pf155 RESA in adults with differential clinical conditions from an Indian zone where malaria is endemic.
    Biswas S; Rao DN; Roy A; Yadav RP; Ghosh SK; Kabilan L
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):219-27. PubMed ID: 8629049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response of naturally infected individuals to recombinant Plasmodium vivax apical membrane antigen-1.
    Rodrigues MH; Rodrigues KM; Oliveira TR; Cômodo AN; Rodrigues MM; Kocken CH; Thomas AW; Soares IS
    Int J Parasitol; 2005 Feb; 35(2):185-92. PubMed ID: 15710439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress towards a malaria vaccine.
    Ramasamy R
    Indian J Malariol; 1987 Jun; 24(1):1-7. PubMed ID: 3326750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.